What do Cochrane systematic reviews say about congenital vascular anomalies and hemangiomas? A narrative review

Detalhes bibliográficos
Autor(a) principal: Guedes Neto,Henrique Jorge
Data de Publicação: 2022
Outros Autores: Kuramoto,Danielle Akemi Bergara, Correia,Rebeca Mangabeira, Santos,Brena Costa, Borges,Amanda da Cunha, Pereda,Mariana Raffo, Aidar,Ana Laura e Silva, Pereira Júnior,Francisco Amadeu, Amaral,Fabio Cabral de Freitas, Vasconcelos,Vladimir Tonello de, Lustre,Wellington Gianoti, Amorim,Jorge Eduardo de, Flumignan,Ronald Luiz Gomes, Nakano,Luis Carlos Uta, Baptista-Silva,José Carlos Costa
Tipo de documento: Artigo
Idioma: eng
Título da fonte: São Paulo medical journal (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802022000200320
Resumo: ABSTRACT BACKGROUND: Congenital vascular anomalies and hemangiomas (CVAH) such as infantile hemangiomas, port-wine stains and brain arteriovenous malformations (AVMs) impair patients’ lives and may require treatment if complications occur. However, a great variety of treatments for those conditions exist and the best interventions remain under discussion. OBJECTIVE: To summarize Cochrane systematic review (SR) evidence on treatments for CVAH. DESIGN AND SETTING: Review of SRs conducted in the Division of Vascular and Endovascular Surgery of Universidade Federal de São Paulo, Brazil. METHODS: A broad search was conducted on March 9, 2021, in the Cochrane Database of Systematic Reviews to retrieve any Cochrane SRs that assessed treatments for CVAH. The key characteristics and results of all SRs included were summarized and discussed. RESULTS: A total of three SRs fulfilled the inclusion criteria and were presented as a qualitative synthesis. One SR reported a significant clinical reduction of skin redness by at least 20%, with more pain, among 103 participants with port-wine stains. One SR reported that propranolol improved the likelihood of clearance 13 to 16-fold among 312 children with hemangiomas. One SR reported that the relative risk of death or dependence was 2.53 times greater in the intervention arm than with conservative management, among 218 participants with brain AVMs. CONCLUSION: Cochrane reviews suggest that treatment of port-wine stains with pulsed-dye laser improves redness; propranolol remains the best option for infantile hemangiomas; and conservative management seems to be superior to surgical intervention for treating brain AVMs.
id APM-1_3e2a7369d9296bacd0b98fc194a19997
oai_identifier_str oai:scielo:S1516-31802022000200320
network_acronym_str APM-1
network_name_str São Paulo medical journal (Online)
repository_id_str
spelling What do Cochrane systematic reviews say about congenital vascular anomalies and hemangiomas? A narrative reviewVascular malformationsHemangiomaArteriovenous malformationsLasers dyeLaser therapyPort-wine stainCongenital vascular anomaliesLaser treatmentABSTRACT BACKGROUND: Congenital vascular anomalies and hemangiomas (CVAH) such as infantile hemangiomas, port-wine stains and brain arteriovenous malformations (AVMs) impair patients’ lives and may require treatment if complications occur. However, a great variety of treatments for those conditions exist and the best interventions remain under discussion. OBJECTIVE: To summarize Cochrane systematic review (SR) evidence on treatments for CVAH. DESIGN AND SETTING: Review of SRs conducted in the Division of Vascular and Endovascular Surgery of Universidade Federal de São Paulo, Brazil. METHODS: A broad search was conducted on March 9, 2021, in the Cochrane Database of Systematic Reviews to retrieve any Cochrane SRs that assessed treatments for CVAH. The key characteristics and results of all SRs included were summarized and discussed. RESULTS: A total of three SRs fulfilled the inclusion criteria and were presented as a qualitative synthesis. One SR reported a significant clinical reduction of skin redness by at least 20%, with more pain, among 103 participants with port-wine stains. One SR reported that propranolol improved the likelihood of clearance 13 to 16-fold among 312 children with hemangiomas. One SR reported that the relative risk of death or dependence was 2.53 times greater in the intervention arm than with conservative management, among 218 participants with brain AVMs. CONCLUSION: Cochrane reviews suggest that treatment of port-wine stains with pulsed-dye laser improves redness; propranolol remains the best option for infantile hemangiomas; and conservative management seems to be superior to surgical intervention for treating brain AVMs.Associação Paulista de Medicina - APM2022-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802022000200320Sao Paulo Medical Journal v.140 n.2 2022reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APM10.1590/1516-3180.2021.0374.r2.15092021info:eu-repo/semantics/openAccessGuedes Neto,Henrique JorgeKuramoto,Danielle Akemi BergaraCorreia,Rebeca MangabeiraSantos,Brena CostaBorges,Amanda da CunhaPereda,Mariana RaffoAidar,Ana Laura e SilvaPereira Júnior,Francisco AmadeuAmaral,Fabio Cabral de FreitasVasconcelos,Vladimir Tonello deLustre,Wellington GianotiAmorim,Jorge Eduardo deFlumignan,Ronald Luiz GomesNakano,Luis Carlos UtaBaptista-Silva,José Carlos Costaeng2022-03-10T00:00:00Zoai:scielo:S1516-31802022000200320Revistahttp://www.scielo.br/spmjhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2022-03-10T00:00São Paulo medical journal (Online) - Associação Paulista de Medicinafalse
dc.title.none.fl_str_mv What do Cochrane systematic reviews say about congenital vascular anomalies and hemangiomas? A narrative review
title What do Cochrane systematic reviews say about congenital vascular anomalies and hemangiomas? A narrative review
spellingShingle What do Cochrane systematic reviews say about congenital vascular anomalies and hemangiomas? A narrative review
Guedes Neto,Henrique Jorge
Vascular malformations
Hemangioma
Arteriovenous malformations
Lasers dye
Laser therapy
Port-wine stain
Congenital vascular anomalies
Laser treatment
title_short What do Cochrane systematic reviews say about congenital vascular anomalies and hemangiomas? A narrative review
title_full What do Cochrane systematic reviews say about congenital vascular anomalies and hemangiomas? A narrative review
title_fullStr What do Cochrane systematic reviews say about congenital vascular anomalies and hemangiomas? A narrative review
title_full_unstemmed What do Cochrane systematic reviews say about congenital vascular anomalies and hemangiomas? A narrative review
title_sort What do Cochrane systematic reviews say about congenital vascular anomalies and hemangiomas? A narrative review
author Guedes Neto,Henrique Jorge
author_facet Guedes Neto,Henrique Jorge
Kuramoto,Danielle Akemi Bergara
Correia,Rebeca Mangabeira
Santos,Brena Costa
Borges,Amanda da Cunha
Pereda,Mariana Raffo
Aidar,Ana Laura e Silva
Pereira Júnior,Francisco Amadeu
Amaral,Fabio Cabral de Freitas
Vasconcelos,Vladimir Tonello de
Lustre,Wellington Gianoti
Amorim,Jorge Eduardo de
Flumignan,Ronald Luiz Gomes
Nakano,Luis Carlos Uta
Baptista-Silva,José Carlos Costa
author_role author
author2 Kuramoto,Danielle Akemi Bergara
Correia,Rebeca Mangabeira
Santos,Brena Costa
Borges,Amanda da Cunha
Pereda,Mariana Raffo
Aidar,Ana Laura e Silva
Pereira Júnior,Francisco Amadeu
Amaral,Fabio Cabral de Freitas
Vasconcelos,Vladimir Tonello de
Lustre,Wellington Gianoti
Amorim,Jorge Eduardo de
Flumignan,Ronald Luiz Gomes
Nakano,Luis Carlos Uta
Baptista-Silva,José Carlos Costa
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Guedes Neto,Henrique Jorge
Kuramoto,Danielle Akemi Bergara
Correia,Rebeca Mangabeira
Santos,Brena Costa
Borges,Amanda da Cunha
Pereda,Mariana Raffo
Aidar,Ana Laura e Silva
Pereira Júnior,Francisco Amadeu
Amaral,Fabio Cabral de Freitas
Vasconcelos,Vladimir Tonello de
Lustre,Wellington Gianoti
Amorim,Jorge Eduardo de
Flumignan,Ronald Luiz Gomes
Nakano,Luis Carlos Uta
Baptista-Silva,José Carlos Costa
dc.subject.por.fl_str_mv Vascular malformations
Hemangioma
Arteriovenous malformations
Lasers dye
Laser therapy
Port-wine stain
Congenital vascular anomalies
Laser treatment
topic Vascular malformations
Hemangioma
Arteriovenous malformations
Lasers dye
Laser therapy
Port-wine stain
Congenital vascular anomalies
Laser treatment
description ABSTRACT BACKGROUND: Congenital vascular anomalies and hemangiomas (CVAH) such as infantile hemangiomas, port-wine stains and brain arteriovenous malformations (AVMs) impair patients’ lives and may require treatment if complications occur. However, a great variety of treatments for those conditions exist and the best interventions remain under discussion. OBJECTIVE: To summarize Cochrane systematic review (SR) evidence on treatments for CVAH. DESIGN AND SETTING: Review of SRs conducted in the Division of Vascular and Endovascular Surgery of Universidade Federal de São Paulo, Brazil. METHODS: A broad search was conducted on March 9, 2021, in the Cochrane Database of Systematic Reviews to retrieve any Cochrane SRs that assessed treatments for CVAH. The key characteristics and results of all SRs included were summarized and discussed. RESULTS: A total of three SRs fulfilled the inclusion criteria and were presented as a qualitative synthesis. One SR reported a significant clinical reduction of skin redness by at least 20%, with more pain, among 103 participants with port-wine stains. One SR reported that propranolol improved the likelihood of clearance 13 to 16-fold among 312 children with hemangiomas. One SR reported that the relative risk of death or dependence was 2.53 times greater in the intervention arm than with conservative management, among 218 participants with brain AVMs. CONCLUSION: Cochrane reviews suggest that treatment of port-wine stains with pulsed-dye laser improves redness; propranolol remains the best option for infantile hemangiomas; and conservative management seems to be superior to surgical intervention for treating brain AVMs.
publishDate 2022
dc.date.none.fl_str_mv 2022-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802022000200320
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802022000200320
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1516-3180.2021.0374.r2.15092021
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Paulista de Medicina - APM
publisher.none.fl_str_mv Associação Paulista de Medicina - APM
dc.source.none.fl_str_mv Sao Paulo Medical Journal v.140 n.2 2022
reponame:São Paulo medical journal (Online)
instname:Associação Paulista de Medicina
instacron:APM
instname_str Associação Paulista de Medicina
instacron_str APM
institution APM
reponame_str São Paulo medical journal (Online)
collection São Paulo medical journal (Online)
repository.name.fl_str_mv São Paulo medical journal (Online) - Associação Paulista de Medicina
repository.mail.fl_str_mv revistas@apm.org.br
_version_ 1754209268194607104